NEW YORK, Oct. 6 (GenomeWeb News) - Saqqara Consultants will collaborate with Cellular Genomics on the development of structure-based drug design utilizing Saqqara's crystallization expertise, the firms announced today.
Terms of the agreement were not disclosed.
Carlsbad, Calif.-based Saqqara specializes in applying X-ray crystallography and molecular modeling to drug discovery programs. Branford, Conn.-based Cellular Genomics applied its chemical genetics platform to in-house drug discovery efforts, as well as to collaborations with pharma and biotech companies, including Affymetrix, Eli Lilly, and Pfizer. The firm recently raised $34.9 million in a Series C private financing.